Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance

NCT05886660 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Motion Sickness, Space
Motion Sickness
Sea Sickness

Interventions

DRUG: DPI-386 Nasal Gel
DRUG: Placebo Nasal Gel
DRUG: DPI-386 Nasal Gel
DRUG: Placebo Nasal Gel

Sponsor

Repurposed Therapeutics, Inc.

Collaborators

[object Object]